MLH1 and endometrial cancer: Loss of MLH1 expression through somatic methylation of the MLH1 promotor region is a common sporadic event in endometrial cancer; MLH1 methylation testing is therefore an effective way of reducing the number of women with MLH1 loss by IHC or whose tumors are MSI-H from expensive germline testing (9).